
Urimove-D 0.4mg/0.5mg Tablet
Marketer
Growmax Medicare Pvt Ltd
Salt Composition
Tamsulosin (0.4mg) + Dutasteride (0.5mg)
Overview Urimove-D 0.4mg/0.5mg Tablet
ProstaRelief 0.4mg/0.5mg tablets combine two active ingredients to alleviate symptoms of benign prostatic hyperplasia (BPH) in adult males. This medication targets urinary difficulties, such as frequent urination or hesitant stream. It does not prevent prostate cancer. ProstaRelief 0.4mg/0.5mg tablets can be administered with or without food, but consistently at the same time daily. Dosage is determined by your physician. Consistent daily use is crucial for optimal symptom management; don't miss doses, even if feeling well. Symptom improvement may take up to four weeks. Report any lack of improvement or worsening symptoms after four weeks. Common side effects include erectile dysfunction, reduced libido, breast tenderness, and ejaculatory issues. Contact your doctor if these persist or are concerning. Dizziness or drowsiness are also possible, particularly at the treatment's outset. Your physician prescribed this medication because the benefits outweigh potential risks. ProstaRelief 0.4mg/0.5mg tablets are not for use by women or children. Inform your doctor of any pre-existing conditions like low blood pressure, liver or kidney disease, as this medication may not be appropriate. Interactions with other medications are possible; disclose all medications to your doctor. Condom use during intercourse may be advised if your partner is or could be pregnant. Regular blood pressure monitoring may be recommended. Alcohol consumption should be avoided due to increased dizziness risk.
Primary Ingredients of Urimove-D 0.4mg/0.5mg Tablet
No text was provided to rewrite.
Uses of Urimove-D 0.4mg/0.5mg Tablet
Managing benign prostatic enlargement
Major Benefits of Urimove-D 0.4mg/0.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Urimove-D 0.4mg/0.5mg tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Urimove-D 0.4mg/0.5mg Tablet:
- Impotence
- Decreased libido
- Ejaculation disorder
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breast enlargement in male
- Breast tenderness in male
- Dizziness
How to use Urimove-D 0.4mg/0.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Urimove-D 0.4mg/0.5mg tablet whole; avoid chewing, crushing, or breaking it. Consumption may coincide with meals or not, though consistent timing is recommended.
How Urimove-D 0.4mg/0.5mg Tablet works:
Urimove-D tablets (0.4mg Tamsulosin/0.5mg Dutasteride) offer dual-action relief from benign prostatic hyperplasia (BPH) symptoms. The alpha-blocker, Tamsulosin, eases urination by relaxing muscles in the bladder neck and prostate. Concurrently, Dutasteride, a 5-alpha-reductase inhibitor, reduces prostate size by lowering levels of the hormone stimulating prostate growth.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Urimove-D 0.4mg/0.5mg tablets and alcohol can induce pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Data on Urimove-D 0.4mg/0.5mg Tablet usage in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Urimove-D 0.4mg/0.5mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Urimove-D 0.4mg/0.5mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Urimove-D 0.4mg/0.5mg tablets to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Urimove-D 0.4mg/0.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Urimove-D 0.4mg/0.5mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Urimove-D 0.4mg/0.5mg Tablet :
Should you forget to take a Urimove-D 0.4mg/0.5mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Urimove-D 0.4mg/0.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Urological Care |
